High Tower Advisors, LLC Paratek Pharmaceuticals, Inc. Transaction History

High Tower Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$1.52 - $2.8 $30,400 - $56,000	20,000 Added 60.61%	53,000 $117,000
Q2 2022 Aug 10, 2022	BUY	$1.73 - $3.09 $14,705 - $26,265	8,500 Added 34.69%	33,000 $64,000
Q2 2021 Aug 06, 2021	BUY	$6.81 - $10.93 $61,290 - $98,370	9,000 Added 58.06%	24,500 $167,000
Q4 2020 Feb 10, 2021	SELL	$4.58 - $7.14 $196 - $307	-43 Reduced 0.28%	15,500 $97,000
Q1 2020 May 21, 2020	BUY	$2.67 - $4.97 $41,499 - $77,248	15,543 New	15,543 $49,000

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.